Impact of a pharmacist-led asthma and COPD respiratory clinic in general practice – The Pharmaceutical Journal

Impact of a pharmacist-led asthma and COPD respiratory clinic in general practice
The Pharmaceutical Journal
Asthma and chronic obstructive pulmonary disease (COPD) continue to account for a large burden of disease in the UK. Despite comprehensive guidelines, more than 1,000 people die from asthma each year and COPD accounts for a leading cause of …

View full post on asthma – Google News

Very poorly controlled asthma lasts more than a decade for half of patients – The Pharmaceutical Journal


The Pharmaceutical Journal

Very poorly controlled asthma lasts more than a decade for half of patients
The Pharmaceutical Journal
The researchers, who presented their results at the American Thoracic Society International Conference on 15–18 May 2016, say that alternative treatment strategies and helping patients to quit smoking could improve the asthma control of these patients.

View full post on asthma – Google News

Late cold weather means asthma risk – Australian Journal of Pharmacy (registration) (blog)


Australian Journal of Pharmacy (registration) (blog)

Late cold weather means asthma risk
Australian Journal of Pharmacy (registration) (blog)
National Asthma Council Australia Director and pharmacist, Stephen Hughes, says that the delayed arrival of colder weather across Australia will hit unprepared families with asthma hard. “Our long stretch of warm temperatures into autumn is likely to

View full post on asthma – Google News

AstraZeneca’s Asthma Drug Shows Positive Results – Wall Street Journal


Wall Street Journal

AstraZeneca's Asthma Drug Shows Positive Results
Wall Street Journal
Bing Yao, head of respiratory medicine at AstraZeneca's MedImmune unit, said benralizumab acted directly on the cells that are thought to cause attacks in patients with severe asthma. He said the Glaxo and Teva drugs, by contrast, act indirectly by
AstraZeneca set to go head to head against GSK with asthma drugFinancial Times
AstraZeneca asthma drug hits goal, to enter competitive marketReuters
AstraZeneca's asthma biologic hits PhIII target, but still behind rivalsFierceBiotech
The Guardian –Philadelphia Business Journal –MarketWatch
all 31 news articles »

View full post on asthma – Google News

AstraZeneca Asthma Drug Shows Positive Results – Wall Street Journal


Reuters

AstraZeneca Asthma Drug Shows Positive Results
Wall Street Journal
Bing Yao, head of respiratory medicine at the company's MedImmune unit, said benralizumab acted directly on the cells that are thought to cause attacks in severe asthma patients. He said the Glaxo and Teva drugs, by contrast, act indirectly by
AstraZeneca asthma drug hits goal, to enter competitive marketReuters
AstraZeneca climbs after positive asthma treatment resultsThe Guardian
AstraZeneca: Asthma drug trial results positiveMarketWatch
FierceBiotech –Nasdaq
all 13 news articles »

View full post on asthma – Google News

Asthma: a breathtaking impact on life – Australian Journal of Pharmacy (registration) (blog)


Australian Journal of Pharmacy (registration) (blog)

Asthma: a breathtaking impact on life
Australian Journal of Pharmacy (registration) (blog)
Woolcock Institute inhaler specialist (and pharmacist) Associate Professor Sinthia Bosnic-Anticevich says, “It is astonishing that despite the high level of asthma awareness in the community, so many people are compromising their well-being through …

View full post on asthma – Google News